质粒
电穿孔
分子生物学
生物
CTL公司*
融合蛋白
细胞毒性T细胞
转染
跨膜结构域
dna疫苗
抗体
重组DNA
抗原
氨基酸
基因
CD8型
生物化学
免疫学
体外
作者
Simona Rolla,Cristina Marchini,Silvia Malinarich,Elena Quaglino,Stefania Lanzardo,Maura Montani,Manuela Iezzi,Mauro Angeletti,Giorgio Ramadori,Guido Forni,Federica Cavallo,Augusto Amici
出处
期刊:Human Gene Therapy
[Mary Ann Liebert]
日期:2008-02-12
卷期号:19 (3): 229-240
被引量:25
摘要
We have shown that electroporation of plasmid carrying extracellular and transmembrane domains (EC-TM plasmid) encoded by the rat neu oncogene triggers a protective immune response toward rat p185(neu)-positive tumors in both wild-type BALB/c mice and cancer-prone rat neu-transgenic BALB-neuT mice. To identify the critical fragments that confer this protective immunity, mice were electroporated with plasmids encoding the TM domain associated with decreasing fragments of the EC domain and the antitumor protection afforded, the titer of antibody, and cytotoxic T lymphocyte (CTL) activity elicited to Neu protein were evaluated. Plasmids encoding EC fragments shortened by 70 (EC1-TM plasmid), 150 (EC2-TM), 230 (EC3-TM), 310 (EC4-TM), and 390 (EC5-TM) NH(2)-terminal residues afforded effective protection. Plasmids encoding shorter truncated proteins were ineffective. When the immunogenic protein was retained in the cytoplasm (EC1-TM, EC2-TM, and EC5-TM), only a CTL response was elicited, whereas when it was also expressed on the membrane (EC4-TM) both CTLs and antibodies were induced. EC4-TM encoding a truncated protein with an EC portion of only 344 amino acids conferred protection on both BALB/c and BALB-neuT mice comparable to that of EC-TM.
科研通智能强力驱动
Strongly Powered by AbleSci AI